chr21-46602390-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006272.3(S100B):āc.26T>Cā(p.Val9Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000335 in 1,613,982 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_006272.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
S100B | NM_006272.3 | c.26T>C | p.Val9Ala | missense_variant | 2/3 | ENST00000291700.9 | NP_006263.1 | |
S100B | XM_017028424.3 | c.26T>C | p.Val9Ala | missense_variant | 2/3 | XP_016883913.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
S100B | ENST00000291700.9 | c.26T>C | p.Val9Ala | missense_variant | 2/3 | 1 | NM_006272.3 | ENSP00000291700 | P1 | |
S100B | ENST00000367071.4 | c.26T>C | p.Val9Ala | missense_variant | 2/4 | 1 | ENSP00000356038 | |||
S100B | ENST00000397648.1 | c.26T>C | p.Val9Ala | missense_variant | 1/2 | 1 | ENSP00000380769 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000164 AC: 25AN: 152148Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.0000278 AC: 7AN: 251362Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135856
GnomAD4 exome AF: 0.0000198 AC: 29AN: 1461834Hom.: 0 Cov.: 34 AF XY: 0.0000110 AC XY: 8AN XY: 727218
GnomAD4 genome AF: 0.000164 AC: 25AN: 152148Hom.: 1 Cov.: 33 AF XY: 0.000215 AC XY: 16AN XY: 74312
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 26, 2022 | The c.26T>C (p.V9A) alteration is located in exon 2 (coding exon 1) of the S100B gene. This alteration results from a T to C substitution at nucleotide position 26, causing the valine (V) at amino acid position 9 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at